Completed PHASE1 INTERVENTIONAL 2-arm NCT01433835

Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers

Sponsor: Microbiotix, Inc.

Updated 6 times since 2017 Last updated: Aug 1, 2013 Started: Sep 30, 2011 Primary completion: Aug 31, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Adult Subjects and is currently completed. Microbiotix, Inc. leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Microbiotix, Inc.

Data source: Microbiotix, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hackensack, United States